Shortcomings & Patient Concerns re: New Study of Breast Brachytherapy (APBI) –
What Women Need to Know Now
Tuesday, Dec. 13, 2011
Call-in number: 1-480-629-9712
Please join us via teleconference to hear statements and discussion by four of the world’s leading clinical researchers in breast brachytherapy (accelerated partial breast irradiation, or APBI).
These experts will highlight their concerns about a controversial — and potentially misleading — new study on APBI presented at last week’s San Antonio Breast Cancer Symposium. They will also provide perspective on what women need to know now about breast cancer radiation therapy.
The teleconference will feature:
Robert Kuske, MD, (Phoenix) Co-Principal Investigator, NSABP B-39 study comparing five-day APBI to six-week whole breast irradiation
Peter D. Beitsch, MD, (Dallas) Co-Principal Investigator of the American Society of Breast Surgeons’ MammoSite Registry
Jayant Viadya, MD, (London, U.K.), pioneer of targeted intraoperative radiotherapy (IORT)
Rakesh Patel, MD, (Pleasanton, Ca.), Chairman, American Brachytherapy Society
This event is open to the first 50 participants, including media and other interested parties.
(Note to media: To ensure your place on the call, please contact Liz Dowling, tel. 415-388-2794; Liz@dowlingdennis.net.)